New Oral Anticoagulants: Is That Plausible to Implement the Data From International Trials to Russian Population?

Cardiovascular Therapy and Prevention (Russian Federation) - Russian Federation
doi 10.15829/1728-8800-2014-5-48-52
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Silicea - Poligraf, LLC

Related search

Is It Time to Implement the International Ovarian Tumour Analysis Rules in Australasia?

Australasian Journal of Ultrasound in Medicine
2017English

Adherence and Persistence to Direct Oral Anticoagulants in Atrial Fibrillation: A Population-Based Study

Heart
Cardiovascular MedicineCardiology
2019English

International Comparison of Data From International Clinical Trials Registry Platform-Registered Clinical Trials

Health
2016English

Bleeding Complications From the Direct Oral Anticoagulants

BMC Hematology
HematologyMolecular Biology
2015English

Switching Among Oral Anticoagulants: Is It Logical?

Current Medical Research and Opinion
Medicine
2019English

Knowledge Is Power: General Practitioners Prescribing of New Oral Anticoagulants in Ireland

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2018English

A New Generation of Oral Direct Anticoagulants

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2012English

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

New Oral Anticoagulants in the Therapy of Antiphospholipid Syndrome

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy